Actinium Pharmaceuticals, Inc. (FRA:7AY1)
1.139
+0.036 (3.26%)
At close: Jan 23, 2026
-6.41% (1Y)
| Market Cap | 30.46M -17.7% |
| Revenue (ttm) | 76.71K +11.1% |
| Net Income | -29.49M |
| EPS | -0.95 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 400 |
| Average Volume | 20 |
| Open | 1.113 |
| Previous Close | 1.103 |
| Day's Range | 1.113 - 1.139 |
| 52-Week Range | 0.998 - 1.821 |
| Beta | n/a |
| RSI | 35.13 |
| Earnings Date | Mar 30, 2026 |